Recruiting A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine NCT07010471 Conditions Brain Diseases, Central Nervous System Diseases, Developmental and Epileptic Encephalopathy 1, +3 more Locations Praxis Research Site — La Jolla, California, United States Praxis Research Site — Gulf Breeze, Florida, United States Praxis Research Site — Chevy Chase, Maryland, United States Praxis Research Site — Roseville, Minnesota, United States View more locations Show fewer locations Loading locations... View Trial Details
Enrolling by Invitation Palliative Care Needs of Children With Rare Diseases and Their Families NCT06938542 Conditions Abnormalities, Multiple, Anxiety Disorders, Arthrogryposis Congenita Multiplex With Intestinal Atresia, +84 more Locations Children's National Hospital — Washington D.C., District of Columbia, United States View Trial Details
Not Yet Recruiting IBIS - Investigating Reliability of BIS and SEDLINE Monitoring in Children With Developmental and Epileptic Encephalopathies (DEE). NCT07585643 Conditions Brain Diseases, Central Nervous System Diseases, Developmental and Epileptic Encephalopathies, +9 more Locations Perth Children's Hospital — Perth, Western Australia, Australia Hospital das Clinicas, São Paulo, Sao Paulo — São Paulo, Brazil View Trial Details
Completed Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures NCT02960347 Conditions Infantile Epileptic-Dyskinetic Encephalopathy, Ohtahara Syndrome Locations Herzog Hospital — Jerusalem, Israel View Trial Details
